Risk assessment of bleeding after gastric submucosal dissection in patients taking anticoagulant drugs and validity evaluation of supplemented guideline for gastrointestinal endoscopy in patients taking antithrombotic drugs: multicenter observational study
Not Applicable
- Conditions
- early gastric cancer
- Registration Number
- JPRN-UMIN000050792
- Lead Sponsor
- ational Hospital Organization Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1740
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who discontinued ESD or underwent surgical treatment due to complications (bleeding, perforation, etc.) or technical reasons during ESD. 2. Those who have not been able to follow up for more than 28 days after ESD 3. Subjects who received additional photodynamic therapy (PDT) after ESD 4. Patients with infiltration deeper than the muscle layer in histopathological evaluation of the resected specimen 5. Patients participating in other interventional trials 6. Those who refuse to use clinical data
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the postoperative bleeding rate before and after the revised guideline in patients taking antithrombotic drugs during gastric ESD in patients taking anticoagulants.
- Secondary Outcome Measures
Name Time Method